These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23448727)

  • 1. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
    Lopera-Mesa TM; Doumbia S; Chiang S; Zeituni AE; Konate DS; Doumbouya M; Keita AS; Stepniewska K; Traore K; Diakite SA; Ndiaye D; Sa JM; Anderson JM; Fay MP; Long CA; Diakite M; Fairhurst RM
    J Infect Dis; 2013 Jun; 207(11):1655-63. PubMed ID: 23448727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.
    Ndour PA; Lopera-Mesa TM; Diakité SA; Chiang S; Mouri O; Roussel C; Jauréguiberry S; Biligui S; Kendjo E; Claessens A; Ciceron L; Mazier D; Thellier M; Diakité M; Fairhurst RM; Buffet PA
    J Infect Dis; 2015 Jan; 211(2):290-7. PubMed ID: 25183768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
    Das D; Tripura R; Phyo AP; Lwin KM; Tarning J; Lee SJ; Hanpithakpong W; Stepniewska K; Menard D; Ringwald P; Silamut K; Imwong M; Chotivanich K; Yi P; Day NP; Lindegardh N; Socheat D; Nguon C; White NJ; Nosten F; Dondorp AM
    Clin Infect Dis; 2013 Mar; 56(5):e48-58. PubMed ID: 23175556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives.
    Flegg JA; Guérin PJ; Nosten F; Ashley EA; Phyo AP; Dondorp AM; Fairhurst RM; Socheat D; Borrmann S; Björkman A; Mårtensson A; Mayxay M; Newton PN; Bethell D; Se Y; Noedl H; Diakite M; Djimde AA; Hien TT; White NJ; Stepniewska K
    Malar J; 2013 Nov; 12():411. PubMed ID: 24225303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives.
    O'Flaherty K; Ataíde R; Zaloumis SG; Ashley EA; Powell R; Feng G; Reiling L; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI
    J Infect Dis; 2019 Aug; 220(7):1178-1187. PubMed ID: 31075171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host immunity to
    Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
    ; Abdulla S; Ashley EA; Bassat Q; Bethell D; Björkman A; Borrmann S; D'Alessandro U; Dahal P; Day NP; Diakite M; Djimde AA; Dondorp AM; Duong S; Edstein MD; Fairhurst RM; Faiz MA; Falade C; Flegg JA; Fogg C; Gonzalez R; Greenwood B; Guérin PJ; Guthmann JP; Hamed K; Hien TT; Htut Y; Juma E; Lim P; Mårtensson A; Mayxay M; Mokuolu OA; Moreira C; Newton P; Noedl H; Nosten F; Ogutu BR; Onyamboko MA; Owusu-Agyei S; Phyo AP; Premji Z; Price RN; Pukrittayakamee S; Ramharter M; Sagara I; Se Y; Suon S; Stepniewska K; Ward SA; White NJ; Winstanley PA
    Malar J; 2015 Sep; 14():359. PubMed ID: 26390866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spread of artemisinin resistance in Plasmodium falciparum malaria.
    Ashley EA; Dhorda M; Fairhurst RM; Amaratunga C; Lim P; Suon S; Sreng S; Anderson JM; Mao S; Sam B; Sopha C; Chuor CM; Nguon C; Sovannaroth S; Pukrittayakamee S; Jittamala P; Chotivanich K; Chutasmit K; Suchatsoonthorn C; Runcharoen R; Hien TT; Thuy-Nhien NT; Thanh NV; Phu NH; Htut Y; Han KT; Aye KH; Mokuolu OA; Olaosebikan RR; Folaranmi OO; Mayxay M; Khanthavong M; Hongvanthong B; Newton PN; Onyamboko MA; Fanello CI; Tshefu AK; Mishra N; Valecha N; Phyo AP; Nosten F; Yi P; Tripura R; Borrmann S; Bashraheil M; Peshu J; Faiz MA; Ghose A; Hossain MA; Samad R; Rahman MR; Hasan MM; Islam A; Miotto O; Amato R; MacInnis B; Stalker J; Kwiatkowski DP; Bozdech Z; Jeeyapant A; Cheah PY; Sakulthaew T; Chalk J; Intharabut B; Silamut K; Lee SJ; Vihokhern B; Kunasol C; Imwong M; Tarning J; Taylor WJ; Yeung S; Woodrow CJ; Flegg JA; Das D; Smith J; Venkatesan M; Plowe CV; Stepniewska K; Guerin PJ; Dondorp AM; Day NP; White NJ;
    N Engl J Med; 2014 Jul; 371(5):411-23. PubMed ID: 25075834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
    Kyaw MP; Nyunt MH; Chit K; Aye MM; Aye KH; Aye MM; Lindegardh N; Tarning J; Imwong M; Jacob CG; Rasmussen C; Perin J; Ringwald P; Nyunt MM
    PLoS One; 2013; 8(3):e57689. PubMed ID: 23520478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999-2009.
    Zwang J; Dorsey G; Mårtensson A; d'Alessandro U; Ndiaye JL; Karema C; Djimde A; Brasseur P; Sirima SB; Olliaro P
    Malar J; 2014 Mar; 13():114. PubMed ID: 24666562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.
    Amaratunga C; Sreng S; Suon S; Phelps ES; Stepniewska K; Lim P; Zhou C; Mao S; Anderson JM; Lindegardh N; Jiang H; Song J; Su XZ; White NJ; Dondorp AM; Anderson TJ; Fay MP; Mu J; Duong S; Fairhurst RM
    Lancet Infect Dis; 2012 Nov; 12(11):851-8. PubMed ID: 22940027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali.
    Maiga AW; Fofana B; Sagara I; Dembele D; Dara A; Traore OB; Toure S; Sanogo K; Dama S; Sidibe B; Kone A; Thera MA; Plowe CV; Doumbo OK; Djimde AA
    Am J Trop Med Hyg; 2012 Jul; 87(1):23-8. PubMed ID: 22764287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
    Hien TT; Thuy-Nhien NT; Phu NH; Boni MF; Thanh NV; Nha-Ca NT; Thai le H; Thai CQ; Toi PV; Thuan PD; Long le T; Dong le T; Merson L; Dolecek C; Stepniewska K; Ringwald P; White NJ; Farrar J; Wolbers M
    Malar J; 2012 Oct; 11():355. PubMed ID: 23101492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance.
    Michael OS; Gbotosho GO; Folarin OA; Okuboyejo T; Sowunmi A; Oduola AM; Happi CT
    Malar J; 2010 Nov; 9():335. PubMed ID: 21092220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours).
    Ayede IA; Falade AG; Sowunmi A; Jansen FH
    Malar J; 2010 Dec; 9():378. PubMed ID: 21194422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.
    Kone AK; Sagara I; Thera MA; Dicko A; Guindo A; Diakite S; Kurantsin-Mills J; Djimde A; Walcourt A; Doumbo O
    Malar J; 2010 Nov; 9():332. PubMed ID: 21092137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children.
    Djimde AA; Maiga AW; Ouologuem D; Fofana B; Sagara I; Dembele D; Toure S; Sanogo K; Dama S; Sidibe B; Doumbo OK
    Parasite; 2016; 23():3. PubMed ID: 26839003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy.
    Kone A; Sissoko S; Fofana B; Sangare CO; Dembele D; Haidara AS; Diallo N; Coulibaly A; Traore A; Toure S; Haidara K; Sanogo K; Sagara I; Beshir KB; Gil JP; Doumbo OK; Djimde AA
    Int J Infect Dis; 2020 Jun; 95():399-405. PubMed ID: 32320811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.